Monophosphoryl Lipid A (MPLA) has become an important component in modern vaccine adjuvant systems. Its application in vaccines such as Cervarix and Shingrix has demonstrated the value of MPLA in helping strengthen immune responses while maintaining a manageable safety profile. As interest in new vaccines, therapeutic vaccines, and advanced immune-based treatments continues to grow, the...